Chapter1 Introduction - 18sep2015
Chapter1 Introduction - 18sep2015
Chapter1 Introduction - 18sep2015
INTRODUCTION
General aims
1. Students understand the definition and scope of biotechnology as well as
environmental biotechnology
Specific Aims
1. Students understand the major foundation and application of biotechnology
2. Students understand patent applications in molecular biology and in fermentation
From World War II up until about 1960, the major new biotechnology products
were antibiotics. Through intense efforts of the pharmaceutical industry, numerous new
antibiotics were discovered and of these around 20 were put into commercial
production. In addition, in this early post-World-War-II period, processes were de-
veloped for the chemical transformation of steroids, and the culture of animal cells for
the production of virus vaccines was perfected.
In the period from 1960 through 1975, new microbial processes for the
production of amino acids and 5-nucleosides as flavor enhancers were developed,
primarily in Japan. In addition, numerous processes for enzyme production for
industrial, analytic, and medical purposes were perfected. During this same period,
successful techniques for the immobilization of enzymes and cells were developed.
During this time a further development was the use of continuous fermentation for the
production of single-cell protein from yeast and bacteria for use as human and animal
food. Single-cell protein processes were developed using microorganisms capable of
using petroleum-based starting materials such as gas oil, alkanes, and methanol. In this
same period, microbial biopolymers such as xanthan and dextran, used as food
additives, were also developed into commercial processes. Somewhat distinct processes
that were advanced during this period were the use of microorganisms for tertiary oil
recovery (an aspect of geomicrobiology) and the perfection of techniques for anaerobic
cultivation of microorganisms, derived out of studies on the sewage treatment process.
Since 1975 biotechnology has entered some important new phases. First was the
development of the hybridoma technique for the production of monoclonal antibodies,
2
Environmental Biotechnology
of interest primarily in the medical diagnosis field. Soon after was the production of
human proteins using genetically engineered Escherichia coli. The first product, human
insulin was introduced in 1982, followed soon by Factor VIII, human growth hormone,
interferons, and urokinase. At present, a vast array of human proteins is in the devel-
opment stage.
Table 1.1 Patent applications in 1984 for three countries with major biotechnology
industries
3
Environmental Biotechnology